Journal of Blood Medicine最新文献

筛选
英文 中文
Presentation and Outcome of Patients with Multiple Myeloma (MM), Single Centre Experience from Windsor Essex Regional Cancer Centre. 温莎埃塞克斯地区癌症中心(Windsor Essex Regional Cancer Centre)的单中心经验:多发性骨髓瘤(MM)患者的表现和预后。
IF 2
Journal of Blood Medicine Pub Date : 2024-02-26 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S434055
Dalia Kashash, Eric McArthur, Caroline Hamm, Rasna Gupta, Sindu Kanjeekal, Mohammad Jarrar, Lisa A Porter, John W Hudson, Adam Renaud, Indryas Woldie
{"title":"Presentation and Outcome of Patients with Multiple Myeloma (MM), Single Centre Experience from Windsor Essex Regional Cancer Centre.","authors":"Dalia Kashash, Eric McArthur, Caroline Hamm, Rasna Gupta, Sindu Kanjeekal, Mohammad Jarrar, Lisa A Porter, John W Hudson, Adam Renaud, Indryas Woldie","doi":"10.2147/JBM.S434055","DOIUrl":"10.2147/JBM.S434055","url":null,"abstract":"<p><strong>Introduction: </strong>Outcomes for patients with multiple myeloma has significantly improved through the years. This is mainly related to the use of novel agents.</p><p><strong>Methods: </strong>This is a retrospective study that reviewed presentation and outcome of 139 patients with multiple myeloma at the Windsor Essex Regional Cancer Centre from Jan. 1, 2015 to Dec. 31, 2019. Median age was 71 years and most patients had higher risk disease (65.5% either R ISS stage II or III). 30% had high risk FISH for myeloma including del.17P, t (4:14), t (14:16) and Gain (1q21). In terms of presentation, 38.8% had anemia (hemoglobin <100g/L), 18.7% had hypercalcemia, 74.1% had skeletal lytic lesions, 38.8% had pathologic fracture and 17.3% had plasmacytoma.</p><p><strong>Results: </strong>Almost all (92%) of the patients were treated using at least one novel agent (proteasome inhibitor or immunomodulators [ImiDs]). Cyclophosphamide, bortezomib, and dexamethasone (CyBorD) was the most used treatment regimen (48.9%) followed by bortezomib, melphalan and prednisone (BMP) at 28.8% and lenalidomide, dexamethasone (LenDex) at 14.4%. With respect to response to therapy, 51.8% had at least Very good partial response (VGPR), while 9.4% had progressive disease. 33% had autologous stem cell transplant. After a median follow up of 2.4 years, median overall survival was 3.7 years. 2 years overall survival and relapse-free survival were 70% and 83%, respectively.</p><p><strong>Discussion: </strong>Our study showed comparable outcome for patients with multiple myeloma despite older age and higher risk disease. Outcome is expected to improve with the introduction of more novel agents.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"101-111"},"PeriodicalIF":2.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140021822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnitude, Associated Factors and Morphological Types of Anemia Among Hospitalized 6-59 Months Age Children at Jimma Medical Center, Southwest Ethiopia - A Hospital-Based Cross-Sectional Study. 埃塞俄比亚西南部吉马医疗中心 6-59 个月大住院儿童贫血的严重程度、相关因素和形态类型--一项基于医院的横断面研究。
IF 2
Journal of Blood Medicine Pub Date : 2024-02-26 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S442240
Regassa Alemu Kebede, Tilahun Yemane, Gebeyaw Arega Berihun, Tolera Ambisa Lamesa, Dereje Abebe Regasa
{"title":"Magnitude, Associated Factors and Morphological Types of Anemia Among Hospitalized 6-59 Months Age Children at Jimma Medical Center, Southwest Ethiopia - A Hospital-Based Cross-Sectional Study.","authors":"Regassa Alemu Kebede, Tilahun Yemane, Gebeyaw Arega Berihun, Tolera Ambisa Lamesa, Dereje Abebe Regasa","doi":"10.2147/JBM.S442240","DOIUrl":"10.2147/JBM.S442240","url":null,"abstract":"<p><strong>Background: </strong>Anemia is among the major public health problems that cause significant morbidity and mortality among children around the world. Anemia in children of age 6 months to 5 years is a major health problem in most developing world countries with estimated prevalence of about 43%.</p><p><strong>Objective: </strong>To determine the magnitude, associated factors and morphological types of anemia among hospitalized 6-59 months age children from June 15 to October 15, 2022 at Jimma Medical Center, southwest Ethiopia.</p><p><strong>Methodology: </strong>Hospital-based cross- sectional study design was conducted from June 15 to October 15, 2022 at Jimma Medical Center, involving 383 hospitalized children aged 6-59 months by employing convenient sampling technique. Data of sociodemographic characteristics and other associated factors of the study individuals waere collected using a pre-structured questionnaire. Clinical data were collected by physical examination and from history of client by medical interns and nurses. Then 3 mL venous blood was collected and analyzed for complete blood count. Data were coded, cleared and entered into EpiData version 4.6 and exported to SPSS version 25 for analysis. Bivariable and multivariable binary logistic regression was used to identify associated factors.</p><p><strong>Results: </strong>The overall prevalence of anemia among hospitalized 6-59 months age children was 57.2%; out of them 30.82% were moderate. In the present study children with malaria infection, AOR = 1.15 (95% CI: 0.017, 0.781), Cchildren with severe malnutrition, AOR = 2.046 (95% CI: 0.306, 1.366), and children with low family income, AOR = 2.6 (95% CI 0.475, 0.894) were independent variables associated with anemia.</p><p><strong>Conclusion and recommendation: </strong>Anemia among study participants is found to be a severe public health problem. Based on this finding, more intervention is needed with health education on nutrition and child feeding.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"87-99"},"PeriodicalIF":2.0,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10906273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140021821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in a Low-Middle Income Country: A Single-Center Experience in West Java, Indonesia. 中低收入国家儿童急性淋巴细胞白血病的存活率和治疗效果:印度尼西亚西爪哇的单中心经验。
IF 2
Journal of Blood Medicine Pub Date : 2024-02-19 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S438042
Monika Hasna Ramadhan, Nur Melani Sari, Stanza Uga Peryoga, Susi Susanah
{"title":"Survival and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in a Low-Middle Income Country: A Single-Center Experience in West Java, Indonesia.","authors":"Monika Hasna Ramadhan, Nur Melani Sari, Stanza Uga Peryoga, Susi Susanah","doi":"10.2147/JBM.S438042","DOIUrl":"https://doi.org/10.2147/JBM.S438042","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to determine the survival rates and treatment outcomes of patients with childhood Acute Lymphoblastic Leukemia (ALL) in a single-center study at Indonesia.</p><p><strong>Patients and methods: </strong>Factors contributing to the relapse and survival of ALL in Bandung, Indonesia, were evaluated. Data were collected from the medical record and the Indonesian Pediatric Cancer Registry (IPCAR). Subsequently, univariate and multivariate analyses were evaluated using Cox proportional hazard regression and Kaplan Meier was used for survival analysis. An analytic observational study was conducted on newly diagnosed children aged 1-18 with ALL from January 2019 to December 2022.</p><p><strong>Results: </strong>A total of 137 children were included in the analysis, 30 (21,9%) were dropped out during treatment and 60.5% died during the study period. Most of the deaths occurred after relapse in 32 (38.5%) with a high early relapse (70.5%), occurring mainly during the maintenance phase (42.4%). At the one-year mark, the observed overall survival (OS) rate was at 36%, while event-free survival (EFS) was lower, at 19%. Univariate Cox regression analysis showed that the leucocyte counts at diagnosis (p=0.005) and response to induction phase (p < 0.008) was associated with the death of ALL. Furthermore, a response to induction phase was significant [hazard ratio 4.67 (CI 95%: 1.64-13.29); p = 0.004] in the multivariate analysis.</p><p><strong>Conclusion: </strong>In conclusion, this study underscored the persistent challenges of high treatment discontinuation rates and the occurrence of very early relapses in low- to middle-income countries (LMICs), which significantly impacted the OS of children diagnosed with ALL.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"77-85"},"PeriodicalIF":2.0,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10887884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Nutritional Anemia Among University Students in Jazan, Saudi Arabia: A Public Health Perspective. 评估沙特阿拉伯贾赞大学生的营养性贫血:公共卫生视角。
IF 2
Journal of Blood Medicine Pub Date : 2024-02-09 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S436673
Waleed Hakami, Gasim Dobie, Khadija A Alneami, Misk Shaabi, Khaled Essawi, Muhammad Saboor, Aymen M Madkhali, Mohammed H Nahari, Hassan H Almasoudi, Mohammad S Akhter, Fasial H Hakami, Fatimah A Zarbatan, Ali Hakamy, Rama M Chandika, Ali A Fageehi, Abdullah A Mobarki, Hassan A Hamali
{"title":"Assessing Nutritional Anemia Among University Students in Jazan, Saudi Arabia: A Public Health Perspective.","authors":"Waleed Hakami, Gasim Dobie, Khadija A Alneami, Misk Shaabi, Khaled Essawi, Muhammad Saboor, Aymen M Madkhali, Mohammed H Nahari, Hassan H Almasoudi, Mohammad S Akhter, Fasial H Hakami, Fatimah A Zarbatan, Ali Hakamy, Rama M Chandika, Ali A Fageehi, Abdullah A Mobarki, Hassan A Hamali","doi":"10.2147/JBM.S436673","DOIUrl":"10.2147/JBM.S436673","url":null,"abstract":"<p><strong>Background: </strong>Nutritional anemia is a significant public health concern worldwide, particularly affecting young adults and children in Saudi Arabia, where inadequate nutrition is considered a primary contributing factor. This study aims to (i) examine the levels of serum iron, folate, and vitamin B<sub>12</sub> in young adult students, with a focus on identifying any deficiencies and their association with anemia; (ii) explore the prevalence of mixed-deficiency anemia resulting from deficiencies in serum iron, folate, and vitamin B<sub>12</sub> (iii) explore how sociodemographic characteristics and dietary habits influence serum iron, folate, and vitamin B<sub>12</sub> levels.</p><p><strong>Materials and methods: </strong>This cross-sectional study encompassed 158 young adult students at Jazan University, Saudi Arabia. Blood samples were collected following a comprehensive questionnaire addressing sociodemographic and health characteristics. These samples were analyzed for complete blood count, serum iron, folate, and vitamin B<sub>12</sub> levels.</p><p><strong>Results: </strong>The findings of this study revealed a significant decrease in serum iron levels, with 70.6% of males and 88% in females exhibiting reduced level. Additionally, low levels of folate were observed in 4% of the study population, while deficiency in vitamin B<sub>12</sub> was found in 2.2% of the study population. However, the simultaneous presence of low serum iron levels along with deficiencies in folate or vitamin B<sub>12</sub> was not observed in the study participants.</p><p><strong>Conclusion: </strong>The study indicates that there is a high incidence of low serum iron and ferritin levels among university students in Saudi Arabia, which poses a considerable public health concern. Conversely, the prevalence of folate and vitamin B<sub>12</sub> deficiencies among the students was comparatively low, and notably, there were no cases where these deficiencies were observed alongside iron deficiency.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"51-60"},"PeriodicalIF":2.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10863464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139729687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Significance of Dual-Specificity Phosphatase 23 Expression in Acute Myeloid Leukemia. 急性髓性白血病中双特异性磷酸酶 23 表达的预后意义
IF 2
Journal of Blood Medicine Pub Date : 2024-02-07 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S437400
Xi Liu, Haihui Zhuang, Fenglin Li, Ying Lu, Renzhi Pei
{"title":"Prognostic Significance of Dual-Specificity Phosphatase 23 Expression in Acute Myeloid Leukemia.","authors":"Xi Liu, Haihui Zhuang, Fenglin Li, Ying Lu, Renzhi Pei","doi":"10.2147/JBM.S437400","DOIUrl":"https://doi.org/10.2147/JBM.S437400","url":null,"abstract":"<p><strong>Background: </strong>Recently, an increasing number of studies have suggested dual-specificity phosphatase 23 (DUSP23) is a critical factor in the development of diffuse connective tissue disease and may be a valuable biomarker for primary human cancers. However, there is a lack of comprehensive studies on the prognostic significance of DUSP23 expression in acute myeloid leukemia (AML).</p><p><strong>Methods: </strong>RNA sequencing data from The Cancer Genome Atlas (TCGA) (AML = 173), Genotype-Tissue Expression (GTEx) (healthy controls = 70) and GEO (AML = 461, healthy controls = 76) databases were used to compare DUSP23 expression between AML patients and healthy controls. The overall survival (OS) of DUSP23 in AML was evaluated using Kaplan-Meier Cox regression. Furthermore, univariate Cox regression and multivariate Cox regression analysis were used to determine whether DUSP23 was an independent prognostic factor for AML. We then verified the expression level and prognostic significance of DUSP23 in our cohort (AML = 128, healthy controls = 31). In addition, functional enrichment analysis of DUSP23-related DEGs was performed through gene set enrichment analysis (GSEA) and protein-protein interaction (PPI) network analysis.</p><p><strong>Results: </strong>The expression level of DUSP23 is significantly higher in AML patients than in healthy controls in TCGA, GTEx, GEO databases and our cohort. By multivariate analysis, high expression of DUSP23 is a poor prognostic indicator of OS in the TCGA database. Next, we verified the role of DUSP23 as an adverse prognostic biomarker in our cohort. Enrichment analysis of related genes showed that DUSP23 may regulate important signal pathways in hematological tumors including the MAPK pathways. It is suggested by the PPI network that DUSP23, along with IMP3, MRPL4, MRPS12, POLR2L, and ATP5F1D may play a role in the process of AML.</p><p><strong>Conclusion: </strong>The study demonstrated high expression of DUSP23 could serve as a poor independent prognostic biomarker in AML.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"35-50"},"PeriodicalIF":2.0,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10859056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139722723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hematological Parameters of Gasoline Station Workers at Hosanna Town, Southwest Ethiopia: A Comparative Cross-Sectional Study. 埃塞俄比亚西南部 Hosanna 镇加油站工人的血液参数:横断面比较研究。
IF 2.1
Journal of Blood Medicine Pub Date : 2024-01-24 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S440989
Tamirat Ersino Kebamo, Tilahun Yemane, Mesay Arkew, Getachew Alemu Walano, Abinet Tantu, Ageze Abose, Kassahun Haile, Solomon Gebre Bawore, Girum Tesfaye Kiya
{"title":"Hematological Parameters of Gasoline Station Workers at Hosanna Town, Southwest Ethiopia: A Comparative Cross-Sectional Study.","authors":"Tamirat Ersino Kebamo, Tilahun Yemane, Mesay Arkew, Getachew Alemu Walano, Abinet Tantu, Ageze Abose, Kassahun Haile, Solomon Gebre Bawore, Girum Tesfaye Kiya","doi":"10.2147/JBM.S440989","DOIUrl":"10.2147/JBM.S440989","url":null,"abstract":"<p><strong>Background: </strong>Human exposure to benzene is associated with many adverse health effects. It is mainly related to impairment of the hematopoietic system and bone marrow suppression, causing abnormalities in hematological parameters. However, the reports obtained from different studies are contradictory, and there are little data regarding the hematological parameters of gas station workers in the study area. Therefore, this study aimed to evaluate the hematological parameters of gas station workers in Hosanna town, southwest Ethiopia, from May 01 to June 15, 2020.</p><p><strong>Methods: </strong>A comparative cross-sectional study was conducted by involving 180 (60 gas-stations workers and 120 controls) participants. Socio-demographic and related data of the study participants were collected using a pre-tested structured questionnaire through face-to-face-interviews. All phases of quality assurance were maintained, and hematological parameters were determined using Uni-Cel DxH 800 automated hematological analyzer. Independent sample <i>T</i>-test, Mann-Whitney <i>U</i>-test, and one-way ANOVA were used for data analysis. Statistical significance was declared at P<0.05.</p><p><strong>Results: </strong>Statistically significant difference was observed in hematological parameters of gasoline-workers and control groups. The mean of red blood cell count among gasoline-workers was significantly reduced as compared to control groups (p=0.007). In addition, the median of hemoglobin levels among gasoline-workers was significantly decreased as compared to the control groups (p=0.001). In contrast, a significant increase was observed in median of absolute eosinophil count among the gasoline-workers as compared to control groups (p=0.01). The mean of mean cell volume was significantly decreased with respect to the duration of work experience (p=0.04).</p><p><strong>Conclusion: </strong>In this study, a statistically significant difference was observed in some hematological parameters of gas station workers compared to the control group. Therefore, medical observation and periodic medical check-ups of the hematological profile should be considered to prevent the development of medical complications.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"21-28"},"PeriodicalIF":2.1,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10822093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report. 联合使用 Brentuximab Vedotin 和 Nivolumab 治疗复发性典型霍奇金淋巴瘤后的严重细胞因子释放综合征和嗜血细胞淋巴组织细胞增多症(HLH)样综合征:病例报告。
IF 2.1
Journal of Blood Medicine Pub Date : 2024-01-24 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S444004
Osama Mosalem, Tanmayi Pai, Mohammed Alqawasma, Marwan Shaikh, K David Li, Muhamad Alhaj Moustafa
{"title":"Severe Cytokine Release Syndrome and Hemophagocytic Lymphohistiocytosis (HLH)-Like Syndrome Following Administration of Combined Brentuximab Vedotin and Nivolumab for Recurrent Classical Hodgkin Lymphoma: A Case Report.","authors":"Osama Mosalem, Tanmayi Pai, Mohammed Alqawasma, Marwan Shaikh, K David Li, Muhamad Alhaj Moustafa","doi":"10.2147/JBM.S444004","DOIUrl":"10.2147/JBM.S444004","url":null,"abstract":"<p><p>Brentuximab vedotin (BV) and nivolumab are increasingly utilized as a novel regimen in patients with relapsed/refractory classical Hodgkin lymphoma (cHL). A 26-year-old male presented to the hospital with refractory diabetic ketoacidosis and multiple electrolyte abnormalities, 9 days after the first dose of brentuximab vedotin and nivolumab for recurrent classical Hodgkin lymphoma. During his hospitalization, he developed multi-organ failure. His workup showed elevated cytokine levels concerning severe cytokine release syndrome (CRS) and hemophagocytic lymphohistiocytosis (HLH)-like syndrome. Despite treatment with CRS- and HLH-directed therapies, his clinical status deteriorated due to ongoing multifactorial shock and worsening multi-organ dysfunction, and comfort care measures were eventually pursued. To our knowledge, there have been no other cases reported of HLH-like syndrome after the combination of BV and nivolumab in patients with cHL. This case of a fatal adverse event following one dose of BV and nivolumab underscores the vital need for close monitoring of patients receiving this treatment regimen.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"29-34"},"PeriodicalIF":2.1,"publicationDate":"2024-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10822081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Erythrocyte Osmotic Fragility and Its Determinants, and Comparison of Hematological Indices Among Type 2 Diabetes Mellitus Patients on Follow-Up at Jimma Medical Center, Southwest Ethiopia. 埃塞俄比亚西南部吉马医疗中心随访的 2 型糖尿病患者红细胞渗透脆性及其决定因素的评估以及血液指标的比较。
IF 2.1
Journal of Blood Medicine Pub Date : 2024-01-22 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S445620
Zenebe Tujara, Wondu Reta, Eyasu Tadesse, Ifa Dereje, Mekonnen Tesfa
{"title":"Assessment of Erythrocyte Osmotic Fragility and Its Determinants, and Comparison of Hematological Indices Among Type 2 Diabetes Mellitus Patients on Follow-Up at Jimma Medical Center, Southwest Ethiopia.","authors":"Zenebe Tujara, Wondu Reta, Eyasu Tadesse, Ifa Dereje, Mekonnen Tesfa","doi":"10.2147/JBM.S445620","DOIUrl":"10.2147/JBM.S445620","url":null,"abstract":"<p><strong>Background: </strong>Diabetes Mellitus (DM) is one of the most prevalent non-communicable diseases worldwide. Approximately 9.3% of the general population was estimated to have DM globally in 2019. Erythrocyte osmotic fragility (EOF) in hyperglycemic patients is expected to increase and determine the rate of erythrocyte hemolysis.</p><p><strong>Purpose: </strong>This study aimed to assess erythrocyte osmotic fragility (EOF) and its determinants and to compare hematological indices among T2DM patients on follow-up at the Jimma Medical Center (JMC), Jimma, Southwest Ethiopia.</p><p><strong>Methods: </strong>A facility-based cross-sectional study involving 124 participants (each 62) of T2DM patients and controls was conducted from October to November 2020 using a structured questionnaire. 5 mL of venous blood was drawn to assess OF, complete blood count, and blood glucose levels. EOF was investigated using a series hypotonic solution of NaCl. The supernatant of the centrifuged sample was transferred to cuvette test tubes, and the hemolysis stage was read on a spectrophotometer. The collected data were coded and entered into Epi-data Version 3.1. The analysis was performed using SPSS Version 23.</p><p><strong>Results: </strong>Compared with non-diabetic controls, patients with T2DM had significantly increased EOF. FBG >126mg/dl (AOR=7.741, 95% CI: 1.562-38.360), PPBG >200 mg/dl (AOR=7.576, 95% CI: 1.519-37.791), RDW (AOR=4.558, 95% CI: 1.136-18.284) were significantly associated with abnormal EOF. A statistically significant increase in total white blood cells and absolute neutrophil counts (P < 0.001) were observed in T2DM patients. From RBC indices, red blood cell distribution width (RDW) and mean corpuscular volume (MCV) were significantly increased in T2DM patients (P < 0.001).</p><p><strong>Conclusion: </strong>This study suggests that EOF was greater in patients with T2DM than in non-diabetic controls and was determined by FBG, PPBG, and RDW. The study also demonstrated that hematological index alterations were higher in T2DM subjects than in non-diabetic controls.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"9-19"},"PeriodicalIF":2.1,"publicationDate":"2024-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10812138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Type 1 Gaucher's Disease. A Rare Genetic Lipid Metabolic Disorder Whose Diagnosis Was Concealed by Recurrent Malaria Infections in a 12-Year-Old Girl. 1型戈谢病。一种罕见的遗传性脂质代谢紊乱,12 岁女孩因反复感染疟疾而被掩盖了诊断。
IF 2.1
Journal of Blood Medicine Pub Date : 2024-01-20 eCollection Date: 2024-01-01 DOI: 10.2147/JBM.S444296
Yekosani Mitala, Abraham Birungi, Branchard Mushabe, John Manzi, Brian Ssenkumba, Raymond Atwine, Siyadora Ankunda
{"title":"Type 1 Gaucher's Disease. A Rare Genetic Lipid Metabolic Disorder Whose Diagnosis Was Concealed by Recurrent Malaria Infections in a 12-Year-Old Girl.","authors":"Yekosani Mitala, Abraham Birungi, Branchard Mushabe, John Manzi, Brian Ssenkumba, Raymond Atwine, Siyadora Ankunda","doi":"10.2147/JBM.S444296","DOIUrl":"10.2147/JBM.S444296","url":null,"abstract":"<p><strong>Introduction: </strong>Gaucher disease is a rare autosomal recessive lysosomal storage disease with unknown prevalence in Africa and no record of the disease exists in Uganda.</p><p><strong>Case presentation: </strong>We report a case of a 12-year-old female, the last born of 6 from a family with no known familial disease who presented with non-neuronopathic Gaucher disease and superimposed malaria. The disease was initially misdiagnosed as hyperreactive malarial splenomegaly but was subsequently confirmed by examination of the bone marrow smear and core. The disease was managed supportively and splenectomy was done due to worsening hematological parameters. She currently takes morphine for bone pains in addition to physiotherapy.</p><p><strong>Conclusion: </strong>Always HMS is a common complication in malaria endemic areas, other causes of hepatosplenomegaly need to be excluded before the diagnosis is made. Diagnosis and treatment of patients with rare conditions like GD is still a challenge in developing countries. Although splenectomy is indicated in GD, it should only be done when it is absolutely necessary.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"15 ","pages":"1-7"},"PeriodicalIF":2.1,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139563881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Hematological Profiles and Prognostic Role of Hemogram-Derived Novel Markers for Diabetes Mellitus and Its Complications Among Type 2 Diabetes Mellitus Adult Patients Attending Bishoftu General Hospital, Central, Ethiopia: A Comparative Cross-Sectional Study. 埃塞俄比亚中部 Bishoftu 综合医院就诊的 2 型糖尿病成人患者的血液学特征评估以及血液图谱衍生的糖尿病及其并发症新型标记物的预后作用:一项横断面比较研究。
IF 2
Journal of Blood Medicine Pub Date : 2023-12-28 eCollection Date: 2023-01-01 DOI: 10.2147/JBM.S435452
Dereje Abebe Regassa, Girum Tesfaye Kiya, Regassa Alemu Kebede, Woyesa Beyene
{"title":"Assessment of Hematological Profiles and Prognostic Role of Hemogram-Derived Novel Markers for Diabetes Mellitus and Its Complications Among Type 2 Diabetes Mellitus Adult Patients Attending Bishoftu General Hospital, Central, Ethiopia: A Comparative Cross-Sectional Study.","authors":"Dereje Abebe Regassa, Girum Tesfaye Kiya, Regassa Alemu Kebede, Woyesa Beyene","doi":"10.2147/JBM.S435452","DOIUrl":"10.2147/JBM.S435452","url":null,"abstract":"<p><strong>Background: </strong>Diabetes is a chronic metabolic syndrome that is a global public health problem. Studies have used hematological parameters and hemogram-derived markers as predictors of poor glycemic and microvascular complications status in diabetics. However, the tendency to use these parameters is not fully evaluated in our context, and the evidence is inadequate. This study aimed to assess the hematological profiles and prognostic role of hemogram-derived novel markers in diabetes mellitus and its complications among DM patients at Bishoftu General Hospital, Ethiopia.</p><p><strong>Methods: </strong>A comparative cross-sectional study was conducted among 261 participants from June 15 to August 12, 2022. A systematic random sampling technique was used to select participants. Data were collected using structured questionnaires, physical measurements, checklists, and laboratory tests. Hematological parameters and fasting blood glucose levels were determined from blood using Sysmex-XN550 and Cobas C311 analyzers, respectively. Blood smear was used to check Hematology analyzer output, and to screen participants for malaria parasites. Collected data were entered into Epi-data 3.1 and exported to SPSS-25. Data were analyzed by Chi-square, Mann-Whitney <i>U</i>-test, Kruskal-Wallis test, Post hoc test, and ROC curve. A P-value <0.05 was considered statistically significant.</p><p><strong>Results: </strong>Total WBC, neutrophils, Monocyte, NLR, MLR, MPVLR, and PLR were significantly higher in poor glycemic and complicated T2DM; meanwhile, measured RBC parameters, RBC indices values were significantly lower in poor glycemic and complicated T2DM. The NLR, MLR, MPVLR, PLR, and NLR, MLR, MPVLR, RPR values were identified as predictors of poor glycemic and complication status in diabetic patients, respectively.</p><p><strong>Conclusion: </strong>Significant increment of some hematological parameters and hemogram-derived markers, and their role in predicting poor glycemic and microvascular complications were identified in diabetic patients. Routine screening of hematological parameters and use of hemogram-derived markers for monitoring of altered health status in DM is very important in the improvement of patient quality of life.</p>","PeriodicalId":15166,"journal":{"name":"Journal of Blood Medicine","volume":"14 ","pages":"681-699"},"PeriodicalIF":2.0,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10758194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139074146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信